In a clinical trial, participants who took a higher dosage of Tirzepatide lost up to 22.5% of their body weight, or about 52 pounds, over the course of 72 weeks
In SURMOUNT-4, all participants received tirzepatide (Mounjaro, Eli Lilly) during a lead-in phase, with the study population achieving a mean weight loss of 20.2% at 36 weeks
Lifestyle Factors That Support Regenerative Therapy Emerging research suggests that certain lifestyle interventions may enhance metabolic health and support neurological function
Different effects of lifestyle intervention in high- and low-risk prediabetes: results of the randomized controlled Prediabetes Lifestyle Intervention Study (PLIS)
While demand for GLP-1 drugs appears to be accelerating, uncertainty around affordability, insurance coverage, and long-term access continues to shape whether interest translates into actual treatment
If you cant find injectable saline, we now offer it as well